Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]
对“PTGER3 通过上调 Ras-MAPK/Erk-ETS1-ELK1/CFTR1 轴诱导卵巢肿瘤发生并赋予顺铂治疗耐药性”的更正 [EBioMedicine 40 (2019) 290-304]
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2022.104194
Rodriguez-Aguayo, Cristian; Bayraktar, Emine; Ivan, Cristina; Aslan, Burcu; Mai, Junhua; He, Guangan; Mangala, Lingegowda S; Jiang, Dahai; Nagaraja, Archana S; Ozpolat, Bulent; Chavez-Reyes, Arturo; Ferrari, Mauro; Mitra, Rahul; Siddik, Zahid H; Shen, Haifa; Yang, Xianbin; Sood, Anil K; Lopez-Berestein, Gabriel
CFTR
肿瘤
肿瘤免疫
治疗耐药
MAPK/ERK
ELK1